Recent Finacing
Recent Raise
Zyngenia is a Rockville-based biotherapeutics company developing multi-specific antibody-like molecules using a proprietary platform to target multiple biological pathways for cancer and autoimmune therapies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor